How should a premenopausal woman with a simple right ovarian follicular cyst ≤5 cm and no symptoms be managed?

Management of Simple Right Ovarian Follicular Cyst ≤5 cm in Asymptomatic Premenopausal Women

No follow-up imaging is required for a simple ovarian follicular cyst ≤5 cm in an asymptomatic premenopausal woman. 1

Evidence-Based Rationale

The current ACR O-RADS guidelines classify simple cysts ≤5 cm in premenopausal women as Category 2 (Almost Certainly Benign, <1% malignancy risk) with an explicit recommendation for no management or follow-up imaging. 1 This represents a significant shift from older practices that routinely recommended surveillance imaging.

Malignancy Risk Profile

• Simple cysts in premenopausal women are benign in 98.7% of cases, with most representing functional cysts (follicular or corpus luteum) that resolve spontaneously within 1-2 menstrual cycles. 2, 1
• Zero cases of cancer were diagnosed in women younger than 50 years in a large study of 12,957 simple cysts followed over 11 years. 1
• The actual malignancy risk is approximately 0.5% or less, and even this figure likely overestimates risk since it comes from surgical cohorts with selection bias. 1

Terminology Clarification

For cysts <3 cm, the term "cyst" should be avoided entirely—these should be described as "follicles" or "corpus luteum" depending on menstrual cycle timing to prevent unnecessary patient anxiety. 1, 3 Cysts between 3-5 cm still represent functional structures in most premenopausal women and require no intervention. 1

Critical Imaging Criteria

The cyst must meet strict "simple cyst" criteria to apply this no-follow-up recommendation:

• Anechoic (completely fluid-filled with no internal echoes)
• Smooth, thin wall
• No septations, solid components, or papillary projections
• Posterior acoustic enhancement
• No internal vascularity on color Doppler 1

Common Pitfall to Avoid

The most frequent error is ordering unnecessary follow-up ultrasounds for small simple cysts that are physiologic. 1 If the cyst has any wall irregularity, septations, or solid components, it would require reclassification and different management—but a true simple cyst needs no surveillance. 1

When Follow-Up IS Indicated

Follow-up imaging at 8-12 weeks should be considered only if:

• The cyst is >5-7 cm (higher threshold for well-characterized simple cysts) 1, 4
• There is any uncertainty about complete visualization of the cyst walls (e.g., cysts approaching 10 cm may require transabdominal views to exclude wall abnormalities) 2, 1
• The patient develops symptoms clearly attributable to the cyst (pain, pressure, torsion concerns) 4

Laboratory Testing

No tumor markers (CA-125, LDH, inhibin B) should be ordered for simple cysts. 1 These markers provide no clinical benefit since simple ovarian cysts carry essentially zero malignancy risk regardless of size or menopausal status. 1 The O-RADS classification explicitly excludes tumor markers from its risk-stratification algorithm for simple cysts. 1

Patient Counseling Points

• Reassure the patient that this represents a normal physiologic structure related to the menstrual cycle, not a tumor or cancer risk. 1
• Explain that most functional cysts resolve within 1-2 menstrual cycles without any intervention. 1
• Advise the patient to return only if she develops severe abdominal pain, fever, or vomiting (signs of potential torsion or rupture). 5
• Emphasize that no follow-up imaging is needed, which saves cost, time, and anxiety. 4